Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Commercial and Regulatory Challenges in Cancer Nanomedicine Publisher



Fateh ST1 ; Fateh ST1 ; Salehinajafabadi A3, 4 ; Aref AR5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Microbiology, School of Biology, University College of Science, University of Tehran, Tehran, Iran
  4. 4. Research Center for New Technologies in Life Science Engineering, University of Tehran, Tehran, Iran
  5. 5. Belfer Center for Applied Cancer Science, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States
  6. 6. Xsphera Biosciences, Boston, MA, United States

Source: Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices Published:2024


Abstract

Despite significant advances in understanding the nature of cancer and the development of effective diagnostic and therapeutic methods, cancer remains a major medical concern across the globe. Nanotechnology provides remarkable opportunities for the diagnosis and treatment of cancer. However, while many nanostructures and methods are reported, few nanomedicines have entered the market for cancer treatment. Translation, commercialization, and regulatory challenges limit the transition of cancer nanomedicines from the bench to the bedside. These challenges could be originated from the biology of cancer, the nature of nanostructures, and the players in the nanomedicine ecosystem industry. This book chapter primarily discusses the significance and extensive applicability of nanomedicines for cancer treatment, the ecosystem of the nanomedicine industry, and the workflow of nanomedicine production and commercialization. Afterward, the challenges in translation, commercialization, and regulations are explained, and potential solutions to the challenges are suggested. This chapter also includes case studies to further elucidate the challenges mentioned earlier. © 2024 Elsevier Inc. All rights reserved.
Related Docs
View other Related Docs
1. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
2. Clinical Applications of Nanomedicine in Cancer Therapy, Drug Discovery Today (2020)
3. Nexus Between in Silico and in Vivo Models to Enhance Clinical Translation of Nanomedicine, Nano Today (2021)
4. Nanopharmaceuticals and Nanomedicines Currently on the Market: Challenges and Opportunities, Nanomedicine (2019)
5. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
6. Co-Delivery Systems: Hope for Clinical Application?, Drug Delivery and Translational Research (2022)
7. Application of Nano-Radiosensitizers in Combination Cancer Therapy, Bioengineering and Translational Medicine (2023)
8. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (6)
Hamid Reza Mirzaei (3)
Other Related Docs
9. Tumor Acidic Environment Directs Nanoparticle Impacts on Cancer Cells, Journal of Colloid and Interface Science (2023)
10. Smart Biomaterials to Enhance the Efficiency of Immunotherapy in Glioblastoma: State of the Art and Future Perspectives, Advanced Drug Delivery Reviews (2021)
11. Potential Role of Thymoquinone to Treat Gastrointestinal Cancers: Insights Into Its Molecular Mechanisms, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
12. Nanostructures for Site-Specific Delivery of Oxaliplatin Cancer Therapy: Versatile Nanoplatforms in Synergistic Cancer Therapy, Translational Oncology (2024)
13. Recent Advances in Regenerative Medicine Strategies for Cancer Treatment, Biomedicine and Pharmacotherapy (2021)
14. Stat3 Targeting by Polyphenols: Novel Therapeutic Strategy for Melanoma, BioFactors (2017)
15. Micrornas As Potential Diagnostic and Prognostic Biomarkers in Melanoma, European Journal of Cancer (2016)
16. Development of a Biomimetic Peptide-Based Nanoformulation Against the Breast Cancer, Acta Medica Iranica (2021)
17. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
18. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)
19. Ignoring the Modeling Approaches: Towards the Shadowy Paths in Nanomedicine, Journal of Controlled Release (2018)
20. Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin, Leukemia Research (2024)
21. Molecular Docking As a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes, Frontiers in Pharmacology (2022)
22. Stimulus-Responsive Liposomes As Smart Nanoplatforms for Drug Delivery Applications, Nanotechnology Reviews (2018)
23. Transferrin Receptor-Mediated Liposomal Drug Delivery: Recent Trends in Targeted Therapy of Cancer, Expert Opinion on Drug Delivery (2022)
24. Application of Nanotechnology in Targeting of Cancer Stem Cells: A Review, International Journal of Stem Cells (2019)
25. Oncometabolites As Biomarkers in Thyroid Cancer: A Systematic Review, Cancer Management and Research (2019)
26. Melatonin As an Anti-Inflammatory Agent in Radiotherapy, Inflammopharmacology (2017)
27. Targeting Non-Apoptotic Cell Death in Cancer Treatment by Nanomaterials: Recent Advances and Future Outlook, Nanomedicine: Nanotechnology# Biology# and Medicine (2020)
28. Applications of Iron Oxide Nanoparticles Against Breast Cancer, Journal of Nanomaterials (2022)
29. Controlled Anti-Cancer Drug Release Through Advanced Nano-Drug Delivery Systems: Static and Dynamic Targeting Strategies, Journal of Controlled Release (2020)
30. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy, Current Cancer Drug Targets (2022)
31. Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside, Frontiers in Oncology (2022)
32. Mesoporous Silica Nanoparticles As a Versatile Nanocarrier for Cancer Treatment: A Review, Journal of Molecular Liquids (2021)
33. Peptidomimetics in Cancer Targeting, Molecular Medicine (2022)
34. Microbiota Alterations and Their Association With Oncogenomic Changes in Pancreatic Cancer Patients, International Journal of Molecular Sciences (2021)
35. Restricting Tumor Lactic Acid Metabolism Using Dichloroacetate Improves T Cell Functions, BMC Cancer (2022)
36. Could Artificial Intelligence Revolutionize the Development of Nanovectors for Gene Therapy and Mrna Vaccines?, Nano Today (2022)
37. The Biomedical Significance of Multifunctional Nanobiomaterials: The Key Components for Site-Specific Delivery of Therapeutics, Life Sciences (2021)
38. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)
39. Micelle-Based Nanoparticles With Stimuli-Responsive Properties for Drug Delivery, Nanotechnology Reviews (2024)
40. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
41. Nano-Scale Delivery Systems for Sirna Delivery in Cancer Therapy: New Era of Gene Therapy Empowered by Nanotechnology, Environmental Research (2023)
42. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
43. Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy, Cancer Treatment and Research Communications (2022)
44. Molecular Mechanisms of Curcumins Suppressing Effects on Tumorigenesis, Angiogenesis and Metastasis, Focusing on Nf-Κb Pathway, Cytokine and Growth Factor Reviews (2016)
45. Bioavailability, Biodistribution, and Toxicity of Fluorescent Metal Nanoclusters, Luminescent Metal Nanoclusters: Synthesis# Characterization# and Applications (2022)
46. Tumor Immunology, Clinical Immunology (2022)
47. Recent Advancements to Engineer Mesenchymal Stem Cells and Their Extracellular Vesicles for Targeting and Destroying Tumors, Progress in Biophysics and Molecular Biology (2023)
48. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
49. Development of Doxorubicin-Loaded Nanostructured Lipid Carriers: Preparation, Characterization, and in Vitro Evaluation on Mcf-7 Cell Line, BioNanoScience (2017)
50. Critical Role of the Long Non-Coding Rnas (Lncrnas) in Radiotherapy (Rt)-Resistance of Gastrointestinal (Gi) Cancer: Is There a Way to Defeat This Resistance?, Pathology Research and Practice (2024)